Endo Brings All Xiaflex Revenue In House With BioSpecifics Acquisition

 
• By Joseph Haas
  
Business teamwork puzzle pieces.
Endo will acquire its long-time partner BioSpecifics in a $658m tender
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business